vs
Side-by-side financial comparison of WEC Energy Group (WEC) and Zoetis (ZTS). Click either name above to swap in a different company.
WEC Energy Group is the larger business by last-quarter revenue ($2.5B vs $2.4B, roughly 1.1× Zoetis). Zoetis runs the higher net margin — 25.3% vs 12.5%, a 12.8% gap on every dollar of revenue. On growth, WEC Energy Group posted the faster year-over-year revenue change (11.1% vs 3.0%). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs -2.7%).
WEC Energy Group is an American energy company based in Milwaukee, Wisconsin. It provides electricity and natural gas to 4.4 million customers across four states.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
WEC vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.4B |
| Net Profit | $316.8M | $603.0M |
| Gross Margin | 63.7% | 70.2% |
| Operating Margin | 17.9% | 31.9% |
| Net Margin | 12.5% | 25.3% |
| Revenue YoY | 11.1% | 3.0% |
| Net Profit YoY | -30.1% | 3.8% |
| EPS (diluted) | — | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $2.4B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.0B | $2.5B | ||
| Q1 25 | $3.1B | $2.2B | ||
| Q4 24 | $2.3B | $2.3B | ||
| Q3 24 | $1.9B | $2.4B | ||
| Q2 24 | $1.8B | $2.4B | ||
| Q1 24 | $2.7B | $2.2B |
| Q4 25 | $316.8M | $603.0M | ||
| Q3 25 | $270.2M | $721.0M | ||
| Q2 25 | $243.0M | $718.0M | ||
| Q1 25 | $725.5M | $631.0M | ||
| Q4 24 | $453.1M | $581.0M | ||
| Q3 24 | $238.6M | $682.0M | ||
| Q2 24 | $210.0M | $624.0M | ||
| Q1 24 | $622.6M | $599.0M |
| Q4 25 | 63.7% | 70.2% | ||
| Q3 25 | 71.1% | 71.5% | ||
| Q2 25 | 71.6% | 73.6% | ||
| Q1 25 | 63.0% | 72.0% | ||
| Q4 24 | 67.7% | 69.5% | ||
| Q3 24 | 72.1% | 70.6% | ||
| Q2 24 | 73.5% | 71.7% | ||
| Q1 24 | 65.4% | 70.6% |
| Q4 25 | 17.9% | 31.9% | ||
| Q3 25 | 21.4% | 37.0% | ||
| Q2 25 | 20.1% | 36.7% | ||
| Q1 25 | 29.8% | 36.5% | ||
| Q4 24 | 25.9% | 31.6% | ||
| Q3 24 | 20.6% | 36.6% | ||
| Q2 24 | 20.6% | 33.0% | ||
| Q1 24 | 30.3% | 34.1% |
| Q4 25 | 12.5% | 25.3% | ||
| Q3 25 | 12.8% | 30.0% | ||
| Q2 25 | 12.1% | 29.2% | ||
| Q1 25 | 23.0% | 28.4% | ||
| Q4 24 | 19.8% | 25.1% | ||
| Q3 24 | 12.8% | 28.6% | ||
| Q2 24 | 11.9% | 26.4% | ||
| Q1 24 | 23.2% | 27.4% |
| Q4 25 | — | $1.37 | ||
| Q3 25 | — | $1.63 | ||
| Q2 25 | — | $1.61 | ||
| Q1 25 | — | $1.41 | ||
| Q4 24 | — | $1.29 | ||
| Q3 24 | — | $1.50 | ||
| Q2 24 | — | $1.37 | ||
| Q1 24 | — | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.6M | — |
| Total DebtLower is stronger | $20.0B | — |
| Stockholders' EquityBook value | $14.1B | $3.3B |
| Total Assets | $51.5B | $15.5B |
| Debt / EquityLower = less leverage | 1.42× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | — | ||
| Q3 25 | $51.1M | $2.1B | ||
| Q2 25 | $23.0M | $1.4B | ||
| Q1 25 | $82.2M | $1.7B | ||
| Q4 24 | $9.8M | $2.0B | ||
| Q3 24 | $322.5M | $1.7B | ||
| Q2 24 | $224.0M | $1.6B | ||
| Q1 24 | $38.9M | $2.0B |
| Q4 25 | $20.0B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $18.9B | — | ||
| Q3 24 | $16.9B | — | ||
| Q2 24 | $16.9B | — | ||
| Q1 24 | $15.4B | — |
| Q4 25 | $14.1B | $3.3B | ||
| Q3 25 | $14.0B | $5.4B | ||
| Q2 25 | $13.7B | $5.0B | ||
| Q1 25 | $13.4B | $4.7B | ||
| Q4 24 | $12.8B | $4.8B | ||
| Q3 24 | $12.4B | $5.2B | ||
| Q2 24 | $12.4B | $5.0B | ||
| Q1 24 | $12.4B | $5.1B |
| Q4 25 | $51.5B | $15.5B | ||
| Q3 25 | $49.8B | $15.2B | ||
| Q2 25 | $48.5B | $14.5B | ||
| Q1 25 | $48.2B | $14.1B | ||
| Q4 24 | $47.4B | $14.2B | ||
| Q3 24 | $45.2B | $14.4B | ||
| Q2 24 | $44.6B | $14.2B | ||
| Q1 24 | $43.9B | $14.3B |
| Q4 25 | 1.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 1.24× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $424.6M | $893.0M |
| Free Cash FlowOCF − Capex | — | $732.0M |
| FCF MarginFCF / Revenue | — | 30.7% |
| Capex IntensityCapex / Revenue | — | 6.7% |
| Cash ConversionOCF / Net Profit | 1.34× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $424.6M | $893.0M | ||
| Q3 25 | $938.9M | $938.0M | ||
| Q2 25 | $853.3M | $486.0M | ||
| Q1 25 | $1.2B | $587.0M | ||
| Q4 24 | $581.8M | $905.0M | ||
| Q3 24 | $729.0M | $951.0M | ||
| Q2 24 | $1.0B | $502.0M | ||
| Q1 24 | $863.6M | $595.0M |
| Q4 25 | — | $732.0M | ||
| Q3 25 | $-625.7M | $805.0M | ||
| Q2 25 | $23.9M | $308.0M | ||
| Q1 25 | $461.5M | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | $-67.3M | $784.0M | ||
| Q2 24 | $343.5M | $370.0M | ||
| Q1 24 | $419.1M | $455.0M |
| Q4 25 | — | 30.7% | ||
| Q3 25 | -29.7% | 33.5% | ||
| Q2 25 | 1.2% | 12.5% | ||
| Q1 25 | 14.7% | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | -3.6% | 32.8% | ||
| Q2 24 | 19.4% | 15.7% | ||
| Q1 24 | 15.6% | 20.8% |
| Q4 25 | — | 6.7% | ||
| Q3 25 | 74.4% | 5.5% | ||
| Q2 25 | 41.3% | 7.2% | ||
| Q1 25 | 22.3% | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | 42.7% | 7.0% | ||
| Q2 24 | 39.2% | 5.6% | ||
| Q1 24 | 16.6% | 6.4% |
| Q4 25 | 1.34× | 1.48× | ||
| Q3 25 | 3.47× | 1.30× | ||
| Q2 25 | 3.51× | 0.68× | ||
| Q1 25 | 1.60× | 0.93× | ||
| Q4 24 | 1.28× | 1.56× | ||
| Q3 24 | 3.06× | 1.39× | ||
| Q2 24 | 4.94× | 0.80× | ||
| Q1 24 | 1.39× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
WEC
| Wisconsin | $1.9B | 73% |
| Illinois | $441.2M | 17% |
| Other States | $165.1M | 7% |
| External Revenues | $74.0M | 3% |
| Otheroperatingrevenues | $8.0M | 0% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
